Clinical Research Directory
Browse clinical research sites, groups, and studies.
Financial Incentives for Smoking Treatment II
Sponsor: University of California, Los Angeles
Summary
Financial incentives for motivating changes in health behavior, particularly for smoking and other morbid habits, are increasingly being tested by health insurers, employers, and government agencies. However, in using incentive programs for smoking cessation, key unanswered structural and theoretical questions remain regarding their effectiveness, acceptability to patients, and economic sustainability. This trial aims to advance the science and implementation of financial incentives for smoking cessation interventions among high-risk, hospitalized smokers. The investigators will pursue two specific aims: 1) comparing the impact of three approaches for smoking cessation on smoking abstinence, use of evidenced-based therapy, and quality of life and 2) comparing the short-term and long term return on investment of using goal directed and outcome-based financial incentives to promote smoking cessation.
Official title: Financial Incentives for Smoking Treatment
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
1058
Start Date
2020-01-06
Completion Date
2025-06-30
Last Updated
2024-05-02
Healthy Volunteers
No
Conditions
Interventions
Smoking cessation counseling (Quitline)
Quitline offers community-based counseling session with a cessation counselor.
Smoking cessation pharmacotherapy (e.g, nicotine replacement therapy)
Participants will be encouraged to speak to their doctors about using highly effective pharmacotherapies for smoking cessation.
Financial incentives for smoking cessation
Participants will receive financial incentives for bioconfirmed smoking cessation.
Financial incentives for use of evidence-based smoking cessation therapies
Participants will receive financial incentives for the use of evidence-based smoking cessation therapies including Quitline counseling, community-based smoking cessation programs and pharmacotherapies
Locations (2)
David Geffen School of Medicine
Los Angeles, California, United States
NYU Langone Health
New York, New York, United States